Affordable Access

Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.

Authors
  • Nieder, Carsten
  • Andratschke, Nicolaus
  • Grosu, Anca L
  • Molls, Michael
Type
Published Article
Journal
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
Publication Date
Jan 01, 2003
Volume
179
Issue
1
Pages
16–20
Identifiers
PMID: 12540980
Source
Medline
License
Unknown

Abstract

Patients with four or more brain metastases seem to represent a group with unfavorable prognosis where remission of brain metastases or administration of more than 30 Gy were not associated with increased survival. The number of patients in RPA class I was too small to draw final conclusions. However, there was absolutely no survival difference between patients in class II (median survival 3.6 months) and III (median 4.2 months).

Report this publication

Statistics

Seen <100 times